Table 1

Baseline characteristics by treatment arm in the ITT population

CharacteristicRandomised groups
tCBT (n=500)Usual care (n=496)
Median (IQR)Median (IQR)
Age (years)58.8 (47.7–68.7)59.5 (47.9–68.9)
N (%) N (%)
Gender
 Male209 (41.8)204 (41.0)
 Female291 (58.2)292 (58.9)
Employment status
 Working (full or part-time)277 (55.4)244 (49.2)
 Unable to work because of health18 (3.6)30 (6.0)
 Retired168 (33.6)177 (35.7)
 Other37 (7.4)45 (9.1)
CWP risk profile:
Illness behaviour score >4
 No1 (0.2)2 (0.5)
 Yes498 (99.6)494 (99.5)
 Not known*1 (0.2)0 (0.0)
Somatic Symptom Scale score >2
 No472 (94.4)462 (93.1)
 Yes28 (5.6)34 (6.9)
Sleep problems score >4
 No1 (0.2)2 (0.4)
 Yes499 (99.8)493 (99.4)
 Not known*0 (0.0)1 (0.2)
CWP risk profile factors present (N)
 2474 (94.8)466 (94.0)
 326 (5.2)30 (6.0)
Median (IQR) (n)† Median (IQR) (n)
Psychological distress (GHQ)1 (0–4) (499)1 (0–4) (494)
Quality of Life (EQ-5D-5L utility score)0.74 (0.65–0.80) (499)0.74 (0.64–0.80) (496)
ICECAP-A0.91 (0.81–0.95) (495)0.90 (0.79–0.95) (491)
Fibromyalgia research criteria
 WPI3 (1–4) (499)2 (1–4) (492)
 SSS4 (3–6) (497)4 (3–5) (494)
  • *Where individuals completed half or fewer items, the score was classified as not known, but individuals could still be eligible for recruitment based on their responses to other items answered.

  • †The number of persons for whom a scale score could be calculated.

  • EQ-5D-5L, EuroQol Questionnaire-five dimensions-five levels; GHQ, General Health Questionnaire; ICECAP-A, ICEpop CAPability measure for Adults; ITT, intention to treat; SSS, Symptom Severity Scale; tCBT, telephone-delivered cognitive–behavioural therapy; WPI, Widespread Pain Index.